SCHEMBL6322237

SCHEMBL6322237

COc1ccc(C(CCNC[C@H](O)COc2cccc3[nH]ccc23)c2ccc(OC)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 7/20 0.65
HTR1A P08908 11/20 0.62
ADRB2 P07550 4/20 0.58
ADRB1 P08588 4/20 0.58
CYP1A2 P05177 2/20 0.58
CYP3A4 P08684 2/20 0.58
LMNA P02545 2/20 0.58
KDM4E B2RXH2 1/20 0.58
USP2 O75604 1/20 0.58
CYP2D6 P10635 1/20 0.58
THRB P10828 1/20 0.58
CYP2C9 P11712 1/20 0.58
TSHR P16473 1/20 0.58
TP53 P04637 1/20 0.58
GLA P06280 1/20 0.58
ALOX15 P16050 1/20 0.58
NFKB1 P19838 1/20 0.58
DRD4 P21917 1/20 0.58
HTR1B P28222 1/20 0.58
HTR2C P28335 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7635345 0.89 HTR1A (0.60) ADRB3HTR1AADRB2ADRB1CYP1A2
SCHEMBL6056296 0.81 HTR1A (0.71) ADRB3HTR1AADRB2ADRB1CYP1A2
SCHEMBL7769568 0.80 HTR1A (0.48) ADRB3HTR1AADRB2ADRB1CYP1A2
SCHEMBL7769566 0.80 HTR1A (0.48) ADRB3HTR1AADRB2ADRB1CYP1A2
SCHEMBL16549970 0.80 ADRB2 (0.70) ADRB3HTR1AADRB2ADRB1CYP1A2
SCHEMBL7641388 0.79 HTR1A (0.61) ADRB3HTR1AADRB2ADRB1CYP1A2
Hydrochloric Acid SCHEMBL6539677 0.79 ADRB3 (0.76) ADRB3ADRB2ADRB1
SCHEMBL7296138 0.78 ADRB3 (0.78) ADRB3ADRB2ADRB1
SCHEMBL4845543 0.78 HTR1A (0.76) ADRB3HTR1AADRB2ADRB1CYP1A2
SCHEMBL8698379 0.77 HTR1A (1.00) ADRB3HTR1AADRB2ADRB1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043371-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-02-24 US disclosed
US-20030181726-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043371-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists ADRB1, ADRB3, ADRB2 ADRB3 2/4885HTR1A 633/4885ADRB2 3/4885
US-20030181726-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists ADRB1, ADRB3, ADRB2 ADRB3 2/4885HTR1A 422/4885ADRB2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.